Since recombinant vaccine is not a live vaccine, it is not contraindicated in immunocompromised persons.
However, it is not recommended by the ACIP at this time. The ACIP is expected to review the evidence for its use in immunocompromised persons and will modify vaccine policy as necessary.
The CDC does express the opinion that the recombinant vaccine can be given to someone who is taking low-dose immunosuppressive medication, is anticipating immunosuppression, or has recovered from an immunocompromising illness.